What is Becton, Dickinson and Company's (BDX.MX) StockRank?

MoatMap's StockRank for Becton, Dickinson and Company (BDX.MX) is 74/100, with a Buy signal. This is a composite score combining Quality (54), Value (72), and Momentum (42) factor ranks across MoatMap's 20,000+ stock universe.

Does Becton, Dickinson and Company have an economic moat?

Becton, Dickinson and Company (BDX.MX) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Becton, Dickinson and Company a buy, hold, or sell?

MoatMap's current signal for Becton, Dickinson and Company (BDX.MX) is Buy, based on a StockRank of 74/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Becton, Dickinson and Company in?

Becton, Dickinson and Company (BDX.MX) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

BDX.MX

BUY

Becton, Dickinson and Company · Healthcare · United States · $41.3B · Avg Vol: $39K/d

StockRank

Get insider-trade alerts

P/E (TTM)

26.7x

ROE

6.7%

D/E

0.7x

Dividend %

2.7%

COMPANY DESCRIPTION

Becton, Dickinson and Company is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents. The company's competitive moat is anchored by its massive installed base of essential medical consumables, such as syringes and catheters, which are critical to daily healthcare operations worldwide. BD operates as a market leader with high customer switching costs and a highly diversified, recession-resistant product portfolio.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	18.9B	19.4B	20.2B	21.8B	5.0%	22.2B	19.2B	19.7B	-5.0%
EPS	5.93	4.97	5.96	5.83	-0.6%	5.74	—	—	—
Shares	283.4M	290.4M	289.1M	285.4M	+0.7%	275.5M	—	—	—
Debt	16.1B	15.9B	20.1B	19.2B	6.1%	17.3B	—	—	—
Equity	25.3B	25.8B	25.9B	25.4B	0.1%	—	—	—	—
Op CF	2.6B	3.0B	3.8B	3.4B	9.2%	3.8B	—	—	—
Inv CF	-3.2B	-716.0M	-5.5B	-818.0M	—	—	—	—	—
Fin CF	-591.0M	-2.0B	2.1B	-3.6B	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+4.4%

SMA 50SMA 200

$153.37

52W High

$201.87

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

5.3%57.9

ROE

6.7%61.8

GP/Assets

18.9%45.3

Op. Margin

14.7%75.0

FCF/Assets

4.8%67.8

Piotroski

783.1

Int. Cover

4.1x48.4

D/E Ratio

0.72x21.9

Current Ratio

0.94x9.5

Value

P/E (TTM)

26.7x43.7

EV/EBITDA

7.0x83.4

P/FCF

15.4x69.0

P/B

0.1x100.0

P/S

1.9x69.1

Div Yield

2.7%61.8

Momentum

52W High %

76%62.3

RS 6M

-24%38.2

SMA 50/200

0.85x26.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$41.3B

P/E (Forward)

—

Gross Margin

47.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BDX.MX are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
BDX.MX	Becton, Dickinson and Company(you)	$41.3B	74	BUY
RMD	ResMed Inc.	$29.1B	78	BUY
WST	West Pharmaceutical Services, Inc.	$24.8B	80	BUY
SOLV	Solventum Corporation	$13.8B	78	BUY
BAX	Baxter International Inc.	$11.4B	70	BUY
ISRG.MX	Intuitive Surgical, Inc.	$144.4B	64	HOLD
ATR	AptarGroup, Inc.	$8.0B	76	BUY
ALGN	Align Technology, Inc.	$12.8B	91	STRONG BUY
TFX	Teleflex Incorporated	$5.7B	71	BUY
COO	The Cooper Companies, Inc.	$13.9B	50	HOLD

Peer medians: ROE -22.3% · P/E 27.5x · Gross margin 49.3%

Becton, Dickinson and Company (BDX.MX) — Stock Score Summary

Becton, Dickinson and Company (BDX.MX) has a MoatMap StockRank of 74/100 based on Quality (54/100), Value (72/100), and Momentum (42/100) factor scores. The current signal is BUY.

Key Financial Metrics

Price	$153.37
Market Cap	$41.3B
P/E (TTM)	26.74
Price/Book	0.10
Return on Equity	6.7%
Return on Invested Capital	5.3%
Debt/Equity	0.72x
Gross Margin	47.1%
Operating Margin	14.7%
Revenue Growth	5.2%
Dividend Yield	2.7%
Free Cash Flow	$2.7B

Becton, Dickinson and Company operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Becton, Dickinson and Company’s (BDX.MX) StockRank?: MoatMap’s StockRank for Becton, Dickinson and Company (BDX.MX) is 74/100, with a Buy signal. It is a composite of Quality (54), Value (72), and Momentum (42) factor ranks across MoatMap’s 20,000+ stock universe.
Does Becton, Dickinson and Company have an economic moat?: Becton, Dickinson and Company (BDX.MX) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Becton, Dickinson and Company a buy, hold, or sell?: MoatMap’s current signal for Becton, Dickinson and Company (BDX.MX) is Buy, based on a StockRank of 74/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Becton, Dickinson and Company in?: Becton, Dickinson and Company (BDX.MX) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).